Headquarters
3, FORBES ROAD, LEXINGTON, MA 02421-7305, US
LEXINGTON, MA, US
AGENUS INC.
From the company
Agenus is a clinical-stage immunotherapy company focused on activating the immune system to fight cancer. Its lead program is botensilimab (BOT) plus balstilimab (BAL), a next-generation CTLA-4 plus PD-1 antibody combination designed to convert immune-cold tumors into immune-active ones. The company reports 12 clinical-stage antibody programs and more than 30 years of immunotherapy innovation.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.